Emergence and dominance of #E coli ST131 CTX-M-27 in a community #paediatric cohort study: independent host factors and #bacterial genetic determinants (Antimicrob Agents Chemother., abstract)

[Source: Antimicrobial Agents and Chemotherapy, full page: (LINK). Abstract, edited.]

Emergence and dominance of E. coli ST131 CTX-M-27 in a community paediatric cohort study: independent host factors and bacterial genetic determinants

André Birgy, Corinne Levy, Marie-Hélène Nicolas-Chanoine, Aurélie Cointe, Claire A. Hobson, Mélanie Magnan, Stéphane Bechet, Philippe Bidet, Robert Cohen, Stéphane Bonacorsi

DOI: 10.1128/AAC.00382-19

 

ABSTRACT

The recent emergence and diffusion in the community of Escherichia coli isolates belonging to the multidrug-resistant and CTX-M-27-producing ST131 C1-M27 cluster, makes this cluster potentially as epidemic as the worldwide E coli ST131 subclade C2 composed of multidrug resistant isolates producing CTX-M-15. Thirty-five extended-spectrum beta-lactamase (ESBL) producing ST131 isolates were identified in a cohort of 1,885 French children over a 5 year-period. They were sequenced to characterize the ST131 E. coli isolates producing CTX-M-27 recently emerging in France. ST131 isolates producing CTX-M-27 (n=17), and particularly those belonging to the C1-M27 cluster (n=14), carried many resistance-encoding genes and predominantly a F1:A2:B20 plasmid type. In multivariate analysis, having been hospitalized since birth (OR=10.9; 95%CI=2.4;48.8; p=0.002) and being cared for in a day-care center (OR=9.4;95%; CI=1.5;59.0; p=0.017) were independent risk factors for ST131 CTX-M-27 fecal carriage compared with ESBL-producing non-ST131 isolates. No independent risk factor was found when comparing CTX-M-15 (n=11) and CTX-M-1/14 (n=7)-producing ST131 isolates with ESBL-producing non-ST131 isolates or with non-ESBL-producing isolates. Several factors may contribute to the increase in fecal carriage of CTX-M-27-producing E. coli isolates: resistance to multiple antibiotics, capacity of the CTX-M-27 enzyme to hydrolyze both cefotaxime and ceftazidime, carriage of a peculiar F-type plasmid, and/or capacity to colonize children who have been hospitalized since birth or who attend day-care centers.

Copyright © 2019 American Society for Microbiology. All Rights Reserved.

Keywords: Antibiotics; Drugs Resistance; E. Coli; Pediatrics; Cefotaxime; Ceftazidime.

——-

Advertisements

Published by

gimi69

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s